Currently Enrolling Studies

The following are our studies currently being enrolled. Please fill out the form below to enroll.

Hypertension/Blood pressure study 2:
Over 18 years of age
On 3 or more blood pressure medicines and still having hypertension (BP > 130/80 )
Hypertension/Blood pressure study 3:
Over 18 years of age
One 1 blood pressure medicine at the maximum tolerated dose and still having hypertension (BP >140/80)
Migraine study:
Over 18 years of age
1 year history of chronic migraine
Age of onset of migraines prior to 50 years of age.
Migraine attacks lasting 4 -72 hours if untreated.
At least 15 headache days per month over the last 3 months.
Hypertriglyceridemia/Very High Triglycerides:
Research Study for patients that have triglycerides over 500 on more than one occasion and on a statin medication
Diabetic Heart Failure Study:
Type II Diabetes Mellitus with an Ejection Fraction more than 45%.
A BMI over 30 and be able to walk for 6 minutes
Women’s Ischemia Trial:
Females must have a normal heart catheterization within 5 years but have signs and/or symptoms of heart issues (chest pain, shortness of breath, etc.)
Type II Diabetes Mellitus and Diabetic Retinopathy:
Age ≥ 18
HbA1c 7%-10%
Additional Eye criteria performed by ophthalmologist
No treatment with GLP-1 or DPP-4 medications within 30 days
No Heart Failure Class IV
No eGFR <30
Type II Diabetes Mellitus A:
-Age ≥ 18
-HbA1c 7%-10%
-Diet and Exercise or Metformin ≥ 1500 mg daily (or max tolerated dose) as monotherapy
-No Diabetic Retinopathy
-No treatment with GLP-1 medications within 90 days
-No Heart Failure Class IV
-eGFR ≥60
-BMI ≥ 25 to ≤ 40
Type II Diabetes Mellitus B:
-Age ≥ 18
-HbA1c 7%-10%
-Treated with basal insulin (Lantus, Levemir, Toujeo, Basaglar, Tresiba) 20-80 units/day and can also be treated with Metformin, Sulfonylureas, DPP-4 inhibitors, SGLT-2 inhibitors, Thiazolindinediones
-BMI ≤ 40
-Not currently using a continuous glucose monitor
-No Heart Failure Class IV
-eGFR > 30
-No Diabetic Retinopathy
Cardiovascular Disease, Chronic Kidney Disease, Systemic Inflammation:
-Age ≥ 18
-eGFR ≥ 15 and < 60
-MI, cardiac revascularization, ≥50% stenosis in major coronary artery, stroke, carotid revascularization, ≥50% stenosis in carotid artery, peripheral arterial disease (PAD) with claudication (from ABI testing), PAD with ≥ 50% stenosis, peripheral artery revascularization, or lower extremity amputation at or above the ankle due to atherosclerotic disease
-No chronic or intermittent dialysis
-No diagnosis of HIV, HEP C, or HEP B

Currently Enrolling Studies Form

Leave this field blank